nitrendipine has been researched along with hydralazine in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (61.54) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Brunner, HR; Hayoz, D; Meister, JJ; Perret, F; Tardy, Y; Waeber, B | 1 |
| Kazda, S; Knorr, A; Neuser, D; Seuter, F; Stasch, JP | 1 |
| Allen, J; Forman, A; Maigaard, S; Skajaa, K | 1 |
| Pedrinelli, R; Tarazi, RC | 2 |
| DiBona, GF | 1 |
| Fleming, JT; Garthoff, B; Mayer, D; Rosen, B; Steinhausen, M | 1 |
| Dahlöf, B; Gudbrandsson, T; Hansson, L; Hellsing, T; Kullman, S; Kuylenstierna, J; Leppert, J; Möller, B; Skogström, K; Svensson, A | 1 |
| Mohácsi, G; Sonkodi, S | 1 |
| Andersson, OK; Granérus, G; Hedner, T | 1 |
| Hedner, T | 1 |
| Kamei, C; Kurokawa, K; Tasaka, K | 1 |
| Muir, AL; Wathen, CG | 1 |
| Deedwania, PC; Fagan, TC; Mehta, JL; Sternleib, C; Vlachakis, N | 1 |
| Brooks, HL; Gross, GJ; Warltier, DC; Zyvoloski, MG | 2 |
| Garthoff, B; Knorr, A | 1 |
| Aguila, E; Baz, R; Lopez, LM; Mehta, JL | 1 |
| Knorr, A; Stoepel, K | 1 |
| Chu, ZX; Liu, JG; Miao, CY; Su, DF; Xu, LP | 1 |
6 trial(s) available for nitrendipine and hydralazine
| Article | Year |
|---|---|
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Atenolol; Blood Pressure; Captopril; Compliance; Dipeptides; Double-Blind Method; Humans; Hydralazine; Hypertension; Lisinopril; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ultrasonography | 1992 |
Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Felodipine; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nitrendipine; Random Allocation | 1988 |
Clinical evaluation of felodipine in hypertensive patients previously treated with a triple drug regimen.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Felodipine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Nitrendipine | 1987 |
The use of felodipine in the treatment of severe hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Felodipine; Female; Humans; Hydralazine; Hypertension; Male; Minoxidil; Nitrendipine; Random Allocation | 1987 |
Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nifedipine; Nitrendipine; Random Allocation; Time Factors | 1984 |
Effects of nitrendipine and hydralazine on plasma catecholamines in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Chromatography, High Pressure Liquid; Dopamine; Drug Evaluation; Epinephrine; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nifedipine; Nitrendipine; Norepinephrine; Posture | 1984 |
20 other study(ies) available for nitrendipine and hydralazine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Long-term protective effects of nitrendipine in experimental hypertension.
Topics: Animals; Arteriosclerosis; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Endothelins; Hydralazine; Hypertension; Minoxidil; Muscle, Smooth, Vascular; Nitrendipine; Organ Size; Rats; Rats, Inbred SHR; Renin | 1991 |
Effects of vasodilators on isolated human uteroplacental arteries.
Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitrendipine; Norepinephrine; Potassium; Prazosin; Pregnancy; Uterus; Vasoconstriction; Vasodilator Agents; Vasopressins | 1991 |
Calcium entry blockade and alpha-adrenergic responsiveness in vivo.
Topics: Animals; Azepines; Blood Pressure; Calcium Channel Blockers; Hydralazine; Nifedipine; Nitrendipine; Nitroprusside; Rats; Receptors, Adrenergic, alpha; Vasoconstriction | 1985 |
Effects of vasodilator antihypertensive agents on renal function.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dogs; Felodipine; Hydralazine; Kidney; Kidney Function Tests; Minoxidil; Nitrendipine; Rats; Rats, Inbred SHR; Vasodilator Agents | 1987 |
Comparison of the effects of antihypertensive drugs on pre- and postglomerular vessels of the hydronephrotic kidney.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Arterioles; Female; Hydralazine; Hydronephrosis; Injections, Intravenous; Kidney Glomerulus; Microcirculation; Minoxidil; Nitrendipine; Rats; Rats, Inbred Strains; Vasodilation | 1987 |
Comparison of BAY e 5009 (nitrendipine) with dihydralazine in Wistar rats with experimentally induced nephritis.
Topics: Animals; Antibodies; Basement Membrane; Blood Pressure; Dihydralazine; Glomerulonephritis; Hydralazine; Male; Nitrendipine; Proteinuria; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Felodipine in combination with a beta-blocker and a diuretic in chronic treatment of patients with refractory primary hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Felodipine; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nitrendipine; Renal Circulation | 1987 |
Hypotensive effects of dihydropyridine derivatives.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Hydralazine; Nicardipine; Nicotinic Acids; Nifedipine; Nimodipine; Nisoldipine; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1985 |
Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
Topics: Animals; Azepines; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Hydralazine; Methoxamine; Nifedipine; Nitrendipine; Nitroprusside; Phenoxybenzamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Vasodilator Agents | 1985 |
Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dogs; Female; Heart Rate; Hemodynamics; Hydralazine; Male; Nifedipine; Nisoldipine; Nitrendipine; Propranolol; Vasodilator Agents | 1984 |
Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Heart Rate; Hydralazine; Hypertension; Nifedipine; Nitrendipine; Rats; Rats, Inbred Strains | 1984 |
Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: alterations in baroreflex sensitivity.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dogs; Female; Heart Rate; Hydralazine; Male; Nifedipine; Nisoldipine; Nitrendipine; Pressoreceptors | 1984 |
Effect of a new calcium antagonist, nitrendipine, on blood pressure and heart rate of conscious, unrestrained dogs.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hydralazine; Hypertension, Renal; Male; Nifedipine; Nitrendipine; Pyridines | 1981 |
Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Hydralazine; Hypertension; Linear Models; Male; Nitrendipine; Rats; Rats, Inbred SHR | 2003 |